BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in BioXcel Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- 0 vs. Q4 2025
- Shares held
- 5.44M
- +2.20M (+67.7%) vs. Q4 2025
- Total value
- $7.28M
- +$2.08M (+40.0%) vs. Q4 2025
- New holders
- 8
- 9 more added
- Sold out
- 8
- 7 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 1 | $1 | 0.00% | −3,184−100.0% | Reduced |
| US Bancorp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Triumph Capital Management | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2 | $3 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 13 | $17 | 0.00% | −4,357−99.7% | Reduced |
| SBI Securities Co., Ltd. | 14 | $19 | 0.00% | −155−91.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 21 | $28 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 25 | $31 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 45 | $54 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 59 | $79 | 0.00% | +47+391.7% | Added |
| EverSource Wealth Advisors, LLC | 60 | $80 | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 112 | $151 | 0.00% | 00.0% | Unchanged |
| Annis Gardner Whiting Capital Advisors, LLC | 156 | $210 | 0.00% | +44+39.3% | Added |
| Washington Trust Advisors, Inc. | 160 | $214 | 0.00% | 00.0% | Unchanged |
| Silver Grove Financial Group, Inc. | 334 | $447 | 0.00% | +334 | New |
| Vanguard Global Advisers, LLC | 493 | $661 | 0.00% | +493 | New |
| GWM Advisors LLC | 1,331 | $1.78K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,718 | $2.30K | 0.00% | +1,718 | New |
| Wells Fargo & Company | 4,319 | $5.79K | 0.00% | −6−0.1% | Reduced |
| Morgan Stanley | 10,588 | $14.2K | 0.00% | +9,124+623.2% | Added |
| Diversify Wealth Management, LLC | 15,000 | $15.6K | 0.00% | 00.0% | Unchanged |
| Portfolio Strategies, Inc. | 12,178 | $16.3K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 16,214 | $21.7K | 0.00% | +465+3.0% | Added |
| Beacon Pointe Advisors, LLC | 18,877 | $25.3K | 0.00% | +18,877 | New |
| Northern Trust Corp | 36,313 | $48.7K | 0.00% | −2,057−5.4% | Reduced |
| HighTower Advisors, LLC | 41,000 | $54.9K | 0.00% | 00.0% | Unchanged |
| Oaktree Fund Advisors, LLC | 42,913 | $57.5K | 0.10% | 00.0% | Unchanged |
| UBS Group AG | 52,788 | $70.7K | 0.00% | +14,448+37.7% | Added |
| Wiley Bros.-Aintree Capital, LLC | 80,864 | $108.4K | 0.00% | +80,864 | New |
| BlackRock, Inc. | 84,282 | $112.9K | 0.00% | −114−0.1% | Reduced |
| Vanguard Fiduciary Trust Co | 84,921 | $113.8K | 0.00% | +84,921 | New |
| FMR LLC | 90,300 | $121.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 92,118 | $123.4K | 0.00% | +28,900+45.7% | Added |
| Man Group plc | 96,473 | $129.3K | 0.00% | +39,648+69.8% | Added |
| Jones Financial Companies LLLP | 131,789 | $166.1K | 0.00% | −5,901−4.3% | Reduced |
| Vanguard Capital Management LLC | 207,339 | $277.8K | 0.00% | +207,339 | New |
| Geode Capital Management, LLC | 230,168 | $308.7K | 0.00% | +24,000+11.6% | Added |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 241,188 | $323.2K | 0.01% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,910,076 | $2.56M | 0.08% | +1,910,076 | New |
| Millennium Management LLC | 1,936,760 | $2.60M | 0.00% | +101,568+5.5% | Added |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −127,501−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −120,102−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,062−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,068−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,303−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −12,079−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,642−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |